Completed PHASE2 INTERVENTIONAL 5-arm NCT01600001

A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)

A Randomized, Double-blind, Placebo-controlled, Phase II Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)

Sponsor: Kissei Pharmaceutical Co., Ltd.

Conditions Chronic Idiopathic Constipation

Interventions KWA-0711 Placebo

Updated 5 times since 2017 Last updated: Oct 29, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01600001, this PHASE2 trial focuses on Chronic Idiopathic Constipation and remains completed. Sponsored by Kissei Pharmaceutical Co., Ltd., it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kissei Pharmaceutical Co., Ltd.

Data source: Kissei Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tokyo and Other Japanese City, Japan